SCHEMBL30633336

SCHEMBL30633336

CCN(C(=O)O)c1cc(-c2ccc3[nH]nc(N)c3c2)ccn1.Nc1n[nH]c2ccc(-c3ccnc(NC(=O)Nc4cccc(Cl)c4)c3)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 10/20 0.51
▸ KIT P10721 5/20 0.47
▸ FLT3 P36888 4/20 0.47
▸ VHL P40337 1/20 0.45
▸ JAK2 O60674 3/20 0.44
▸ JAK1 P23458 1/20 0.44
▸ EEF2K O00418 1/20 0.43
▸ PLK1 P53350 1/20 0.43
▸ LCK P06239 2/20 0.43
▸ CSF1R P07333 2/20 0.43
▸ LYN P07948 2/20 0.43
▸ FLT1 P17948 2/20 0.43
▸ FLT4 P35916 2/20 0.43
▸ BLK P51451 2/20 0.43
▸ NTRK1 P04629 2/20 0.43
▸ ABL1 P00519 1/20 0.43
▸ FYN P06241 1/20 0.43
▸ SRC P12931 1/20 0.43
▸ CNR1 P21554 1/20 0.42
▸ PLK4 O00444 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30633303 0.92 JAK2 (0.48) KDRKITFLT3JAK2JAK1
SCHEMBL30633306 0.91 CNR1 (0.51) KDRKITFLT3JAK2JAK1
SCHEMBL30633386 0.90 JAK2 (0.41) KDRKITFLT3JAK2JAK1
SCHEMBL30633320 0.90 KDR (0.46) KDRKITFLT3JAK2LCK
SCHEMBL26685808 0.88 KDR (0.62) KDRKITFLT3VHLJAK2
SCHEMBL30633365 0.88 KDR (0.62) KDRKITFLT3VHLJAK2
SCHEMBL30633326 0.88 DYRK1A (0.45) JAK2CLK2MAPK1
SCHEMBL30633377 0.85 JAK2 (0.51) KDRKITFLT3JAK2JAK1
SCHEMBL30633315 0.84 JAK2 (0.46) KDRKITFLT3JAK2CNR1
SCHEMBL30633352 0.80 JAK2 (0.56) KDRKITFLT3JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522597-A1 IKK INHIBITORS Cancer Research Technology Limited (GB) 2025-03-19 — — EP disclosed
WO-2023218201-A1 IKK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2023-11-16 — — WO disclosed
Send feedback